Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Baotailing Capsules is a Traditional Chinese Medicine (TCM) product developed and manufactured by Zhejiang Xinmingzhu Pharmaceutical. It is formulated as an oral capsule and is officially approved in China for the treatment of threatened miscarriage and habitual miscarriage, particularly those categorized under the "kidney deficiency" pattern in TCM theory. The formulation consists of several herbal ingredients, including *Rehmannia glutinosa*, *Cuscuta chinensis*, *Dipsacus asper*, *Eucommia ulmoides*, and *Asini Corii Colla*. These components work synergistically to tonify the kidneys, nourish the blood, and stabilize the fetus. Pharmacologically, the preparation is intended to support the uterine environment and reduce the risk of pregnancy loss by modulating hormonal balance and providing anti-inflammatory effects, although its precise molecular mechanisms of action involve multiple pathways characteristic of polyherbal therapies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on baotailing capsules.